Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25029918 | 0.83 | CA2 (0.44) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20208600 | 0.80 | KCNH2 (0.65) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL30956097 | 0.78 | CYP1A2 (0.50) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL1252407 | 0.77 | CA2 (0.59) | CA2 | |
| SCHEMBL20209368 | 0.76 | CYP1A2 (0.84) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL27776938 | 0.76 | CA2 (0.57) | CA2 | |
| SCHEMBL25028275 | 0.76 | CA2 (0.43) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL1252500 | 0.74 | CA2 (0.51) | CA2 | |
| SCHEMBL25030257 | 0.74 | HTR1A (0.55) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL30956087 | 0.74 | MAOB (0.46) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018095287-A1 | BENZOHETEROCYCLYL ALKYLAMINE COMPOUND AND USE THEREOF | 华东理工大学 | 2018-05-31 | — | — | WO | disclosed |